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9:15 a.m. 
806-1 Emergency Coronary Artery Bypass Grafting Following 
Percutaneous Coronary interventions in the Stent Era 
sSeshadri, Naveen Acharya, Penny Houghtaling, Eugene Blackstone, Stephen 
G. Ellis, Patrick L. Whiilow, Cleveland Clinic Foundation, C/eve/and, Ohio. 
Background: Since the advent of percutaneous coronary interventions. technological 
advances, adjunctive pharmacology and increased operator experience have resulted in 
lower complication rates. We sought to determine the prevalence of and indications for 
emergency coronary artery bypass grafting (EMCABG) following percutaneous intervan- 
tions (PCI) at our institution. 
Methods: A review of all PCls performed between 1992 to 2000. Data was entered pro- 
spectively in a computerized database at the time of PCI and updated at hospital dis- 
charge. 
Results: A total of 16, 561 PCI procedures were performed during the study period. There 
was a need for EMCABG in 113 (0.61%) cases overall. There was a decrease in the 
occurence of EMCABG over time from 1992-2000 (p<O.OOi) (Figure). 
Stents and glycoprotein IlWllla inhibitors were used in 6/<1% (1992-1994), 31/12% (1995), 
59/33% (19X-1997) and 76/7.2% (1996-2000) of all PCls respectively. The predominant 
indications for EMCABG wsre extensive dissection (56% in 1992-96 vs 41% in 1997-00) 
and perforation (19% in 1992-96 vs 24% in 1997-00). 
Summery: 
There has been a significant decrease in the prevalence of EMCABG following PCls over 
the last decade and EMCABG is extremely uncommon in the new millenium. 
9:30 a.m. 
806-2 Outcome of PTCA and Stenting in Diabetic and 
Nondiabetic Patients: A Report From the Total 
Occlusion Study of Canada (TOSCA) investigators 
wDzavik, Kok Meng Yee. Todd Anderson, Eric A. Cohen, John Man&i, Diane 
Catellier, Gerald Barbeau, John Ducas, Charfes Lazzam, Jeffrey R. Burton, Peter B. 
Berger, Christopher E. Buller, Toronto Genera/Hospital, University Health Nefwork, 
Toronto, Ontario, Canada. 
BACKGROUND: Prior studies have suggested worse outcome after percutaneous coro- 
nary intervention in diabetic patients with CAD compared to those without diabetes. How- 
ever, outcome after stenting of non-acute coronary occlusions in those with diabetes is 
unknown. The main aim of this analysis was to compare angiographic and clinical outcome 
in diabetic and non-diabetic patients randomized to PTCA alone or stenting in the TOSCA 
Trial, a multicenter randomized trial of stsnting with a heparincoated Palmaz-Shatz stent 
vs. angioplasty alone in patients with non-acute coronary occlusions (TIMI 0 and 1) 
METHODS: Baseline and follow-up QCA parameters and l-year clinical outcomes for 
PTCA and Stent groups were compared for diabetic and non-diabetic patients. Student t- 
test, Chi-square and Kaplan-Meier analyses were used. 
kuns: 
CONCLUSIONS: Stenting after PTCA of non-acute coronary occlusions results in superior 
net gain and appears to result in similar magnitude of angiographic improvement and 
reduction in NR in diabetic and non-diabetic patients. The increased need for repeat 
revascularization in diabetic patients is a reflection of .sn increase in revascularization of 
non-target vessels. 
Outcome In diabetics and non-diabetics randomized lo stent or PTCA 
Variable Diabetes No Diabetes 
PTCA Stent pvalue PTCA Stent pvalue 
rl=36 n=30 n=170 n=172 
Acute gain in mm 1.6+0.4 2.4*0.6 <O.OOOl 1.9+0.5 2.4i0.6 <O.OOOl 
Net gain in mm. 1.1+0.7 1.5~0.7 0.015 1.2+0.7 1.4~0.7 0.005 
Failure of sustained patency in % 16.4 3.7 0.076 19.6 12.1 0.071 
NR 31.6 20.0 0.261 30.0 21.5 0.023 
Any revascularization 42.1 36.7 0.604 38.8 28.5 0.052 
9:45 a.m. 
806-3 Three-Year Foiiow-Up Results of Argentine Randomized 
Study Coronary Angiopiasty With Stenting Versus 
Bypass Surgery in Patients With Multiple Vessel 
Disease (ERACI ii) 
medo E. R&&uez, Mlximo Rodriguez Alemparte, Julio Baldi. Jose Navia, Jorge 
Martinez, Daniel Vogel, Alajandro Delacasa, Victor Bern&i, Carlos Ferndndez Pereirs., 
lgor Palacios. William O’Neill, Ofamsndi Hospital, Buenos Aires. Argentina, William 
Beaumont Hospital, Royal Oak, Michigan. 
Background: We previously presented the hospital and one year follow up results of the 
Argentine randomized trial percutaneous transluminal coronary revascularization (PTCR) 
with stenting versus coronaty artery bypass graft surgery (CABG) in multivessel disease 
(ERACI Il).Oblsctlve:The purpose of the present study was to report the 3 years follow 
up outcome of the ERACI II study. Methods: This trial included 460 patients (pts) with 
multivessel disease and clinical indication of myocardial revascularization (92% of unsta- 
ble angina) randomized to stent (225) or CABG (225). The primary end point of the study 
was to compare freedom from major adverse events (MACE) as death, myocardial inf- 
arction (Ml), stroke and repeat PTCRICABG, between both rsvascularization procedures 
at 30 days, 1.3 and 5 years of follow up. Results: At 3 years of follow up there were no 
differences in freedom from MACE or from Ml between both groups. Survival at the end 
of the follow up was still significantly better with stent technique compared to CABG (95% 
versus 90.2% respectively, p< 0.044) however this advantage was lower than we 
reported previously (p= 0.017 in favor to PTCR at one year). Freedom from repeat revas- 
cularization procedures were significantly better with surgery (94.7% versus 75%, p< 
0.00001 respectively) and these differences increased during the entire follow up period 
(pz 0.001 in favor to CABG at one year).Concluslon:ln this selected group of pts with 
multivessel disease, at 3 years of follow up, PTCR with stent implantation showed better 
survival than conventional bypass surgery. Repeat revascularization procedures were 
significantly higher in the PTCR group. 
IO:00 a.m. 
806-4 impact of Angiographic Restenosts Detected by 
Routine Anglographic Follow-Up at Six Months on 
Long-Term Mortality 
HelmutSchuhlen, Adnan Kastrati. J&g Hausleitsr, Josef Dirschinger, Veroniks 
Eimannsberger, Julinda Mehilli. Albert Schbmig, Deutsches Herzzenlrum. Munich, 
Germany, 1. Med. Klinik mchts der Isar. Munich, Germany. 
Background. Angiographic routine follow-up at six months (FU angio) is the most sensi- 
tive tool to detect restenosis after coronary stent placement. The impact of angiographic 
restenosis identified by FU angio on long-term prognosis of patients has been ques- 
tioned. 
Methods. We analyzed all patients with FU angio after successful coronary stem place- 
ment from May 1992 throughout December 1996. At our institutions, all patients are rou- 
tinely scheduled for FU angio at six months, and 1972 of 2409 patients consented to this 
procedure. 
Results. Of 1972 patients with FU angio, 562 patients (26.5%) had angiographic rest- 
enosis (>50% diameter stenosis). During the 4-year follow-up, 6.6% of patients with rest- 
enosis died, compared to 6.0% of those without restenosis (p=.OZ). Patients with 
restenosis had several significant differences in clinical and angiographic characteristics: 
they were older, had more diabetes, had more complex and longer lesions in smaller 
vessels which required more stents. However, in a multivariate model including all these 
variables together with restenosis, only older age (adjusted risk, 2.78; 95% confidence 
interval, 2.05-3.77) and restenosis (1.46; 1 .Ol-2.10) were identified as significant and 
independent risk factors for long-term mortality. Of all 562 patients with restenosis, 331 
had a target vessel revascularization procedure (NR) due to symptoms, stenosis ssver- 
ihy or evidence of ischemia. Patients with NR had a long-term mortality of 6.2%. com- 
pared to 9.7% in patients withoutTVA (p=.51). 
Conclurfons. Angiographic restenosis is independently and significantly associated with 
an increased long-term mortality, independent of other well-known risk factors for the 
development of restenosis. 
IO:15 a.m. 
806-5 Increased CKMB Release Is a Trade-Off for Optimal 
Stent implantation: An intravascular Ultrasound Study 
v, R. Merhan. G. Mint& G. Dangas, Y. Koboyashi. A. Abizaid, D. Ashby, T. 
Limpijankit, R. Narasimaiah. I. Hjazi. N. Kipshidze, A. L. Lansky, G. W. Stone, J. W. 
Moses, M. B. Leon, Cardiovascular Research Foundation. Lenox Hill Heart & Vascular 
Institute, New York, New York. 
Introduction. Creatine kinase MB (CKMB) elevation after percutaneous coronary lnter- 
ventions (PCI) is associated with late mortality. We evaluated the impact of aggressive 
stent expansion on both CK-MB release and clinical outcome. 
Methods. We identified 969 consecutive patients (lM19 coronary lesions) who underwent 
intravascular ultrasound (IVUS)-guided stenting; restenotic and saphenous vein graft 
lesions were excluded. Patients were classified based on final stent cross-sectional area 
(CSA): Group I (stent CSAc 70% ref. lumen CSA, 11~117 pts, n=126 lesions), Group II 
@tent CSA: 70-100% ref. lumen CSA, n=551 pts, n=562 lesions), and Group III @tent 
CSA> 100% ref. lumen CSA, n=321 pts, n=327 lesions). CK-MB values were measured 
by radioimmunoassay at baseline, 6 and 24 hours after PCI. 
Results. Baseline patient characteristics and lesion morphology including arc of calcium 
(~~0.7) and diabetes (~~0.67) were similar among the groups. There was a stepwise 
